Brainreader
The company provides AI-enabled brain volumetric analysis software called Neuroreader® for clinicians, imaging centers, and research institutions. The FDA-cleared and CE-marked tool quantifies 83 brain regions from routine MRIs to identify subtle atrophy patterns associated with neurodegenerative disorders like Alzheimer’s and traumatic brain injury. It delivers automated reports in under 10 minutes, integrating with existing PACS workflows to support diagnostic precision and longitudinal monitoring.
Visit websiteAalborg, Denmark
Healthtech
Artificial Intelligence
Medical Devices
Diagnostics
Funding summary
- Total raised
- €6.6M
- Funding rounds
- 1
Investors in Brainreader
Investors on record for Brainreader. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Brainreader?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors